Zhejiang Xinguang Pharmaceutical Co., Ltd. (SHE:300519)

SHE:300519 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Operating Revenue	260.25	267.54	270.28	351.37	320.77	282.96
Other Revenue	0.12	0.12	0.11	0.12	0.11	0.12
Revenue	260.36	267.66	270.4	351.49	320.88	283.08
Revenue Growth (YoY)	-6.56%	-1.01%	-23.07%	9.54%	13.35%	-2.81%
Cost of Revenue	174.02	177.89	160.03	169.81	145.29	128.68
Gross Profit	86.35	89.77	110.37	181.68	175.58	154.4
Selling, General & Admin	42.18	41.5	43.64	50.61	49.27	46.59
Research & Development	12.96	12.62	15.13	15.55	13.52	12.01
Other Operating Expenses	3.69	3.5	3.43	4.26	4.22	4.07
Operating Expenses	58.84	57.74	61.51	70.86	66.85	62.71
Operating Income	27.51	32.03	48.87	110.82	108.73	91.69
Interest & Investment Income	29.65	23.55	22.98	14.09	23.03	19.29
Other Non Operating Income (Expenses)	-0.2	-0.01	-0.02	-0.01	-0.01	2.74
EBT Excluding Unusual Items	56.96	55.57	71.83	124.9	131.74	113.72
Gain (Loss) on Sale of Assets	-0	-0.07	-0.29	-	-0.71	-
Asset Writedown	0.27	-0.01	0.02	0	-0.02	-0.45
Other Unusual Items	1.74	1.51	1.6	0.7	0.95	1.52
Pretax Income	58.97	57.01	73.16	125.6	131.96	114.8
Income Tax Expense	6.87	6.62	8.8	16.78	17.68	15.82
Net Income	52.1	50.39	64.36	108.82	114.28	98.98
Net Income to Common	52.1	50.39	64.36	108.82	114.28	98.98
Net Income Growth	-8.18%	-21.70%	-40.86%	-4.78%	15.46%	5.41%
Shares Outstanding (Basic)	163	163	161	160	161	160
Shares Outstanding (Diluted)	163	163	161	160	161	160
Shares Change (YoY)	0.67%	1.03%	0.54%	-0.58%	0.83%	0.30%
EPS (Basic)	0.32	0.31	0.40	0.68	0.71	0.62
EPS (Diluted)	0.32	0.31	0.40	0.68	0.71	0.62
EPS Growth	-8.79%	-22.50%	-41.18%	-4.23%	14.52%	5.08%
Free Cash Flow	53.58	48.23	37.3	109.78	127.64	102.34
Free Cash Flow Per Share	0.33	0.30	0.23	0.69	0.79	0.64
Dividend Per Share	0.300	0.300	0.400	0.500	0.600	0.600
Dividend Growth	-25.00%	-25.00%	-20.00%	-16.67%	-	33.33%
Gross Margin	33.16%	33.54%	40.82%	51.69%	54.72%	54.54%
Operating Margin	10.57%	11.97%	18.07%	31.53%	33.88%	32.39%
Profit Margin	20.01%	18.83%	23.80%	30.96%	35.62%	34.96%
Free Cash Flow Margin	20.58%	18.02%	13.80%	31.23%	39.78%	36.15%
EBITDA	42.48	46.97	63.64	124.88	121.59	104.22
EBITDA Margin	16.32%	17.55%	23.54%	35.53%	37.89%	36.82%
D&A For EBITDA	14.97	14.93	14.77	14.05	12.86	12.53
EBIT	27.51	32.03	48.87	110.82	108.73	91.69
EBIT Margin	10.57%	11.97%	18.07%	31.53%	33.88%	32.39%
Effective Tax Rate	11.65%	11.61%	12.03%	13.36%	13.40%	13.78%
Revenue as Reported	260.36	267.66	270.4	351.49	320.88	283.08

Source: S&P Global Market Intelligence. Standard template. Financial Sources.